Search

7 September 2022 - We invite the public to get involved in health technology assessment (HTA) processes. We welcome input from patients, carers, members of the public, health professionals or members of a consumer interest group.

12 March 2025 - Some people are at higher risk of getting COVID-19, or of getting severe illness, getting long COVID or dying from COVID-19. If you are at high risk, you should take extra precautions – especially getting vaccinated – and talk to your doctor. You might be eligible for antiviral medicines.

2 August 2021 - A statement from the Australian Technical Advisory Group on Immunisation (ATAGI) regarding COVID-19 vaccines in the setting of transmission of the Delta variant of concern.

7 April 2025 - Certain jobs and industries are linked with a greater risk of getting and/or transmitting a disease preventable by vaccination.

11 June 2026 - The Consumer Medicines Line (1300 Medicines) will close on 30 July 2026. Find out where to get medicines advice and how to report medication side effects.

19 March 2021 - This statement from the Australian Technical Advisory Group on Immunisation (ATAGI) updates advice previous provided on 16 March. It follows the European Medicines Agency (EMA) safety review of the AstraZeneca COVID-19 vaccine.

4 August 2025 - This collection contains regular updates for disability service providers about COVID-19 vaccines.

18 June 2025 - This set of resources are designed to help disability providers promote COVID-19 vaccination to their employees.

1 July 2026 - The Australian Medical Research Advisory Board (AMRAB) advises the Minister for Health and Ageing on prioritising spending from the Medical Research Future Fund (MRFF).

23 May 2021 - A joint statement from the Australian Technical Advisory Group on Immunisation (ATAGI) and the Thrombosis and Haemostasis society of Australia and New Zealand (THANZ) on Thrombosis with Thrombocytopenia Syndrome (TTS) and the use of COVID-19 Vaccine AstraZeneca.